Permanent treatment discontinuations because of AEs were more common with liraglutide (12.6% [n = 16]) vs semaglutide (3.2% [n = 4]) and placebo (3.5% [n = 3])
Semaglutide is a synthetic peptide that mimics the action of human GLP-1, a hormone that increases insulin secretion and suppresses glucagon secretion (Nauck et al., 2016)
Elevated prolactin suppresses ovulation, which can delay periods or stop them entirely
Ozempic curbs the appetite and keeps its takers full for longer
Given that infants' gastrointestinal and metabolic systems are immature, even small exposures could theoretically affect glucose regulation, growth, or feeding patterns
Investigators, Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira), Diabetes care, 37 (2014) 29262933